GEMER P1 MG TAB

1. All Details: Specifications
Dosage Form: Uncoated bilayer tablets (specifically formulated with an extended-release layer).
Storage Conditions: Store at room temperature, protected from light and moisture.
Batch Number (B.No.): GTH1047A
Manufacturing Date (Mfg. Dt.): 03/2026
Expiry Date (Exp. Dt.): 02/2028
Manufacturing License Number: M.L.: 374/DR/Mfg/2013
Maximum Retail Price (M.R.P.): Rs. 172.00 per 10 Tablets (Regulatory print reads: “M.R.P. ₹ (Incl. of all taxes) per 10 Tablets”).
Product Authentication Identifier: 5257516
2. GeneralBrand: Gemer® P1
Generic Name: Glimepiride, Pioglitazone Hydrochloride and Extended Release Metformin Hydrochloride Tablets
Quantity: 10 Tablets per strip.
Type: Allopathic Pharmaceutical / Prescription Drug (indicated by the red cautionary prescription warning blocks).
Form Factor: Blister strip containing solid oral tablets.
Maximum Shelf Life: 23 months (from March 2026 to February 2028).
Food Preference / FSSAI: Not Applicable. This is a critical multi-ingredient prescription medication for managing metabolic conditions, not a food product or dietary supplement. It falls under national drug regulation authorities rather than the FSSAI, and it does not display vegetarian or non-vegetarian food preference icons.
3. Product Details: Ingredients
Each uncoated bilayer tablet contains:
Glimepiride IP: 1 mg
Pioglitazone Hydrochloride IP equivalent to Pioglitazone: 15 mg
Metformin Hydrochloride IP (as extended release): 500 mg
Excipients: q.s. (Quantity Sufficient)
Colour: Carmoisine
4. Directions: How to Use
Administration Guide: Tablets should be swallowed whole and not to be chewed or crushed.
Dosage: As directed by the Specialist.
Statutory Warning Labels:
SCHEDULE G PRESCRIPTION DRUG – CAUTION: It is dangerous to take this preparation except under medical supervision.
SCHEDULE H PRESCRIPTION DRUG – WARNING: To be sold by retail without the prescription of a Specialist.
5. Description
Therapeutic Application: Gemer P1 is a triple fixed-dose combination oral anti-diabetic medication. It combines three distinct blood glucose-lowering mechanisms: a sulfonylurea (Glimepiride) to stimulate pancreatic insulin secretion, a thiazolidinedione (Pioglitazone) to reduce peripheral insulin resistance, and a biguanide (Metformin Hydrochloride in an extended-release system) to decrease hepatic glucose production. It is standardly prescribed under strict medical specialist oversight for managing complex Type 2 diabetes mellitus.
Visual Presentation: The packaging features a protective silver metallic blister backing with a distinctively patterned central column featuring orange and teal foil details, standard red cautionary notification grids, and a scannable QR code instruction stating “Scan QR code and check product authenticity.”
6. Manufacturer Information
Manufactured in India by: sun pharma laboratories ltd.
Factory Address: Vill: Kokjhar, Mirza Palashbari Road, P.O.: Palashbari, Dist: Kamrup, Assam-781128.
7. Marketed By
Marketed By: Sun Pharmaceutical Industries Ltd.